» Articles » PMID: 20833343

The Dimensions of the CRC Problem

Overview
Publisher Elsevier
Specialty Gastroenterology
Date 2010 Sep 14
PMID 20833343
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer is a significant health problem, the importance of which will increase substantially in the coming years, both in more, as well as in less developed regions of the world. The present paper describes the dimensions of the problem from an epidemiologic viewpoint as well as from the perspective of policy makers and professionals seeking to control the disease. Currently, colorectal cancer is the third most common cancer and the fourth most common cause of cancer deaths worldwide, with 1.2 million estimated cases and 609,000 estimated deaths in 2008. Based on demographic trends, the annual incidence is expected to increase by nearly 80% to 2.2 million cases over the next two decades and most of this increase will occur in the less developed regions of the world (62%). These regions are ill equipped to deal with the rapidly increasing demand for cancer treatment resulting from population growth and higher life expectancy. Concerted efforts to control colorectal cancer are therefore of great importance worldwide. They will require allocation of additional resources and should be based on an appropriate balance between prevention, diagnosis and treatment.

Citing Articles

Spatial analysis of risk factors related to colorectal cancer in Iran: An ecological study.

Montaseri Z, Kargar H, Sharafi M, Afrashteh S Health Sci Rep. 2024; 7(10):e70120.

PMID: 39377026 PMC: 11456510. DOI: 10.1002/hsr2.70120.


Predictive modeling of colorectal cancer using exhaustive analysis of microbiome information layers available from public metagenomic data.

Murovec B, Deutsch L, Stres B Front Microbiol. 2024; 15:1426407.

PMID: 39252839 PMC: 11381387. DOI: 10.3389/fmicb.2024.1426407.


The association of preoperative hematologic parameters with short-term clinical outcomes in rectal cancer: A feature importance analysis.

Orafaie A, Shahabi F, Mehri A, Ansari M, Kasraeifar S, Ghiyasi M Cancer Med. 2024; 13(10):e7225.

PMID: 38778698 PMC: 11112298. DOI: 10.1002/cam4.7225.


Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran.

Jafari A, Far S, Dehghani M, Ravangard R Cancer Control. 2023; 30:10732748231180679.

PMID: 37314727 PMC: 10286541. DOI: 10.1177/10732748231180679.


The Association between Colorectal Cancer and Colonoscopic Conditions in Saudi Patients: A 10-Year Cross-Sectional-Retrospective Study.

Alharbi S, Flemban A, Kabrah S, Khogeer A, Alahmdi H, Mansour A Ethiop J Health Sci. 2022; 32(6):1157-1166.

PMID: 36475247 PMC: 9692146. DOI: 10.4314/ejhs.v32i6.13.